MENU
+Compare
CLDX
Stock ticker: NASDAQ
AS OF
Apr 24 closing price
Price
$19.58
Change
+$0.15 (+0.77%)
Capitalization
1.3B

CLDX Celldex Therapeutics Forecast, Technical & Fundamental Analysis

Celldex Therapeutics Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CLDX with price predictions
Apr 24, 2025

CLDX's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for CLDX turned positive on April 14, 2025. Looking at past instances where CLDX's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CLDX's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 15, 2025. You may want to consider a long position or call options on CLDX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLDX advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

CLDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CLDX entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.727) is normal, around the industry mean (14.237). P/E Ratio (0.000) is within average values for comparable stocks, (63.881). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.827). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (178.571) is also within normal values, averaging (255.011).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CLDX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CLDX is expected to report earnings to rise 6.59% to -75 cents per share on May 01

Celldex Therapeutics CLDX Stock Earnings Reports
Q1'25
Est.
$-0.76
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.15
The last earnings report on February 27 showed earnings per share of -70 cents, missing the estimate of -68 cents. With 452.68K shares outstanding, the current market capitalization sits at 1.30B.
A.I. Advisor
published General Information

General Information

a developer of immunotherapy technologies for the treatment of cancer and other diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
53 Frontage Road
Phone
+1 908 200-7500
Employees
160
Web
https://www.celldex.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARYMX12.69N/A
N/A
American Century Global Real Estate A
MERIX17.44N/A
N/A
The Merger Fund I
KESGX14.33N/A
N/A
Kennedy Capital ESG SMID Cap I
MDDVX18.76N/A
N/A
BlackRock Equity Dividend Inv A
NWXUX9.61N/A
N/A
Nationwide International Sm Cp R6

CLDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
+0.77%
BEAM - CLDX
51%
Loosely correlated
+1.51%
DNLI - CLDX
51%
Loosely correlated
+4.17%
KYMR - CLDX
49%
Loosely correlated
+9.32%
NTLA - CLDX
48%
Loosely correlated
+1.11%
RVMD - CLDX
47%
Loosely correlated
+3.04%
More